UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men

Science translational medicine, 2012-09, Vol.4 (151), p.151ra125

2012

Volltextzugriff (PDF)

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

British journal of cancer, 2018-11, Vol.119 (10), p.1208-1214

2018

Volltextzugriff (PDF)

Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours

British journal of cancer, 2021-08, Vol.125 (4), p.510-519

2021

Volltextzugriff (PDF)

Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug

Journal of the American Chemical Society, 2013-03, Vol.135 (11), p.4567-4572

2013

Volltextzugriff (PDF)

Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy

ACS nano, 2017-09, Vol.11 (9), p.8668-8678

2017

Volltextzugriff (PDF)

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

Investigational new drugs, 2015-02, Vol.33 (1), p.201-214

2015

Volltextzugriff (PDF)

Black phosphorus nanosheets and gemcitabine encapsulated thermo-sensitive hydrogel for synergistic photothermal-chemotherapy

Journal of colloid and interface science, 2019-11, Vol.556, p.232-238

2019

Volltextzugriff (PDF)

Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery

Journal of the American Chemical Society, 2013-08, Vol.135 (31), p.11657-11662

2013

Volltextzugriff (PDF)

Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV‑1 Prevention

Journal of medicinal chemistry, 2020-08, Vol.63 (15), p.8554-8566

2020

Volltextzugriff (PDF)

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

The New England journal of medicine, 2015-11, Vol.373 (21), p.2048-2058

2015

Volltextzugriff (PDF)

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma

British journal of cancer, 2018-03, Vol.118 (6), p.793-801

2018

Volltextzugriff (PDF)

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission

Science translational medicine, 2011-12, Vol.3 (112), p.112re4

2011

Volltextzugriff (PDF)

Local bacteria affect the efficacy of chemotherapeutic drugs

Scientific reports, 2015-09, Vol.5 (1), p.14554, Article 14554

2015

Volltextzugriff (PDF)

Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles

Journal of colloid and interface science, 2016-11, Vol.481, p.107-116

2016

Volltextzugriff (PDF)

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study

Neuro-oncology (Charlottesville, Va.), 2015-02, Vol.17 (2), p.289-295

2015

Volltextzugriff (PDF)

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

AIDS research and human retroviruses, 2013-02, Vol.29 (2), p.384-390

2013

Volltextzugriff (PDF)

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer

Gut, 2018-03, Vol.67 (3), p.497-507

2018

Volltextzugriff (PDF)

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

Cancer Chemotherapy and Pharmacology, 2016-07, Vol.78 (1), p.1-12

2016

Volltextzugriff (PDF)

Cellular pharmacology of gemcitabine

Annals of oncology, 2006-05, Vol.17 (suppl-5), p.v7-v12

2006

Volltextzugriff (PDF)

Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors

Annals of oncology, 2018-05, Vol.29 (5), p.1304-1311

2018

Volltextzugriff (PDF)

Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer

Journal of controlled release, 2015-03, Vol.201, p.90-99

2015

Volltextzugriff (PDF)

Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery

European journal of pharmaceutical sciences, 2014-08, Vol.60, p.80-89

2014

Volltextzugriff (PDF)

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3778-3785

2009

Volltextzugriff (PDF)

Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy

Nanoscale, 2016-01, Vol.8 (1), p.283-291

2016

Volltextzugriff (PDF)

Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice

Biochemical pharmacology, 2020-10, Vol.180, p.114127-114127, Article 114127

2020

Volltextzugriff (PDF)

1 – 25 von 1.160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.122)
Mit Volltextzugriff
(975)

Publikationsform

Artikel
(1.160)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Deoxycytidine - Analogs & Derivatives
(1.067)
Science & Technology
(1.050)
Humans
(1.016)
Life Sciences & Biomedicine
(1.001)
Deoxycytidine - Pharmacokinetics
(753)
Deoxycytidine - Administration & Dosage
(627)
Female
(592)
Oncology
(535)
Male
(533)
Pharmacology & Pharmacy
(490)
Biological And Medical Sciences
(484)
Medical Sciences
(481)
Middle Aged
(439)
Gemcitabine
(415)
Pharmacology. Drug Treatments
(390)
Aged
(385)
Adult
(380)
Animals
(359)
Pharmacokinetics
(347)
Antimetabolites, Antineoplastic - Pharmacokinetics
(310)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.150)
Ingenta.com
(532)
Journals@Ovid Full Text
(469)
EZB Electronic Journals Library
(456)
Springer journals
(266)
Publisher or Other Site
(261)
IngentaConnect Journals
(245)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(219)
Elsevier ScienceDirect Journals
(157)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(127)
Wiley Online Library All Journals
(95)
Taylor & Francis
(80)
Taylor & Francis Journals
(79)
Wiley Online Library Full Collection 2018
(71)
Taylor & Francis Online
(60)
Nature
(50)
Nexis Uni
(43)
SAGE Journals
(25)
Oxford Journals
(20)
Oxford Journals 2020 Medicine
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours

Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug

Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

Black phosphorus nanosheets and gemcitabine encapsulated thermo-sensitive hydrogel for synergistic photothermal-chemotherapy

Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery

Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV‑1 Prevention

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission

Local bacteria affect the efficacy of chemotherapeutic drugs

Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

Cellular pharmacology of gemcitabine

Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors

Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer

Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy

Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice

Suchergebnisse filtern